LPL Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Buy |
80,951
+7,511
| +10% | +$167K | ﹤0.01% | 3603 |
|
|
2025
Q4 | $1.9M | Buy |
73,440
+47,224
| +180% | +$1.12M | ﹤0.01% | 3464 |
|
|
2025
Q3 | $676K | Sell |
26,216
-40,977
| -61% | -$1.01M | ﹤0.01% | 4377 |
|
|
2025
Q2 | $1.61M | Buy |
67,193
+42,288
| +170% | +$1.07M | ﹤0.01% | 3332 |
|
|
2025
Q1 | $619K | Buy |
24,905
+11,584
| +87% | +$277K | ﹤0.01% | 3971 |
|
|
2024
Q4 | $251K | Buy |
+13,321
| New | +$234K | ﹤0.01% | 4666 |
|
|
2024
Q3 | – | Sell |
-7,464
| Closed | -$214K | – | 5266 |
|
|
2024
Q2 | $214K | Buy |
+7,464
| New | +$212K | ﹤0.01% | 4519 |
|
|
2024
Q1 | – | Sell |
-6,448
| Closed | -$218K | – | 4997 |
|
|
2023
Q4 | $218K | Buy |
+6,448
| New | +$189K | ﹤0.01% | 4329 |
|
|
2023
Q1 | – | Sell |
-6,113
| Closed | -$236K | – | 4559 |
|
|
2022
Q4 | $236K | Sell |
6,113
-689
| -10% | -$33.5K | ﹤0.01% | 3853 |
|
|
2022
Q3 | $362K | Sell |
6,802
-689
| -9% | -$38.3K | ﹤0.01% | 3421 |
|
|
2022
Q2 | $437K | Buy |
7,491
+77
| +1% | +$5.04K | ﹤0.01% | 3321 |
|
|
2022
Q1 | $566K | Buy |
7,414
+161
| +2% | +$10.7K | ﹤0.01% | 3095 |
|
|
2021
Q4 | $436K | Buy |
7,253
+1,033
| +17% | +$57K | ﹤0.01% | 3397 |
|
|
2021
Q3 | $348K | Buy |
6,220
+649
| +12% | +$37.4K | ﹤0.01% | 3530 |
|
|
2021
Q2 | $338K | Buy |
5,571
+2,101
| +61% | +$133K | ﹤0.01% | 3494 |
|
|
2021
Q1 | $243K | Buy |
+3,470
| New | +$248K | ﹤0.01% | 3621 |
|
|
2016
Q1 | – | Sell |
-2,968
| Closed | -$221K | – | 3180 |
|
|
2015
Q4 | $221K | Buy |
+2,968
| New | +$168K | ﹤0.01% | 2751 |
|
|
2014
Q3 | – | Sell |
-10,393
| Closed | -$955K | – | 2765 |
|
|
2014
Q2 | $955K | Buy |
+10,393
| New | +$791K | 0.01% | 1359 |
|
Other funds holding PCRX
DPCM
VPM
VCM
